Cargando…
Correction: Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
Autores principales: | Shen, Peng, Cheng, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105410/ https://www.ncbi.nlm.nih.gov/pubmed/33963179 http://dx.doi.org/10.1038/s41419-021-03779-5 |
Ejemplares similares
-
Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
por: Shen, Peng, et al.
Publicado: (2020) -
Correction to: Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway
por: Chi, Yuan, et al.
Publicado: (2021) -
Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway
por: Chi, Yuan, et al.
Publicado: (2020) -
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
por: Qu, Le, et al.
Publicado: (2016) -
Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway
por: Zhang, Wei, et al.
Publicado: (2022)